130 related articles for article (PubMed ID: 1509292)
1. Continuous infusion intravenous immunoglobulin is associated with a reduced incidence of infection and achieves higher serum immunoglobulin G levels than intermittent infusion following bone marrow transplantation.
Spitzer TR; Cottler-Fox M; Sullivan P; Lynch M; Tefft MC; Pickle LW; Cirenza E; Cahill R; Deeg HJ; Sacher R
Semin Hematol; 1992 Jul; 29(3 Suppl 2):123-6. PubMed ID: 1509292
[No Abstract] [Full Text] [Related]
2. A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantation.
Winston DJ; Antin JH; Wolff SN; Bierer BE; Small T; Miller KB; Linker C; Kaizer H; Lazarus HM; Petersen FB; Cowan MJ; Ho WG; Wingard JR; Schiller GJ; Territo MC; Jiao J; Petrarca MA; Tonetta SA
Bone Marrow Transplant; 2001 Jul; 28(2):187-96. PubMed ID: 11509937
[TBL] [Abstract][Full Text] [Related]
3. Statistical methods for the analysis of repeated measurements of serum immunoglobulin levels.
Pickle LW; Cottler-Fox M
Semin Hematol; 1992 Jul; 29(3 Suppl 2):116-22. PubMed ID: 1509291
[No Abstract] [Full Text] [Related]
4. Risk factors for cytomegalovirus pneumonia following allogeneic bone marrow transplantation after prophylaxis with intravenous immunoglobulin.
Krischer J; Elfenbein G; Babington R; Hong R; Jansen J; Lazarus H; Winton E; Rand K
Semin Hematol; 1992 Jul; 29(3 Suppl 2):89-95. PubMed ID: 1324530
[No Abstract] [Full Text] [Related]
5. Some but not all benefits of intravenous immunoglobulin therapy after marrow transplantation appear to correlate with IgG trough levels.
Cottler-Fox M; Lynch M; Pickle LW; Cahill R; Spitzer TR; Deeg HJ
Bone Marrow Transplant; 1991 Jul; 8(1):27-33. PubMed ID: 1655138
[TBL] [Abstract][Full Text] [Related]
6. Comparison of two doses of intravenous immunoglobulin after allogeneic bone marrow transplants.
Abdel-Mageed A; Graham-Pole J; Del Rosario ML; Longmate J; Ochoa S; Amylon M; Elfenbein GJ; Janiec J; Jansen J; Lazarus HM
Bone Marrow Transplant; 1999 May; 23(9):929-32. PubMed ID: 10338049
[TBL] [Abstract][Full Text] [Related]
7. Intravenous immunoglobulin and CMV-seronegative blood products for prevention of CMV infection and disease in bone marrow transplant recipients.
Winston DJ; Ho WG; Bartoni K; Champlin RE
Bone Marrow Transplant; 1993 Sep; 12(3):283-8. PubMed ID: 8241988
[TBL] [Abstract][Full Text] [Related]
8. Experience with sandoglobulin in bone marrow transplantation.
Tutschka PJ; Copelan EA
Int J Cell Cloning; 1986; 4 Suppl 1():181-8. PubMed ID: 3018102
[No Abstract] [Full Text] [Related]
9. Alternate applications of immunoglobulin following bone marrow transplantation.
Copelan EA; Avalos BR; Kapoor N; Bechtel T; Tutschka PJ
Semin Hematol; 1992 Jul; 29(3 Suppl 2):96-9. PubMed ID: 1324531
[No Abstract] [Full Text] [Related]
10. Immune globulin (GAMMAGARD) prophylaxis of CMV infections in patients undergoing organ transplantation and allogeneic bone marrow transplantation.
Fehir KM; Decker WA; Samo T; Young JB; Lederer E; Lawrence EC
Transplant Proc; 1989 Feb; 21(1 Pt 3):3107-9. PubMed ID: 2539691
[No Abstract] [Full Text] [Related]
11. [Immunoglobulin therapy in patients after autologous and allogeneic bone marrow transplantation].
Körholz D; Grünewald S; Burdach S; Göbel U
Infusionsther Transfusionsmed; 1993 Apr; 20 Suppl 1():68-71; discussion 72. PubMed ID: 8499754
[TBL] [Abstract][Full Text] [Related]
12. Intravenous immunoglobulin: immune modulatory effects in vitro and clinical effects in allogeneic bone marrow transplant recipients.
Klaesson S; Ringdén O; Markling L; Tammik L
Transplant Proc; 1995 Dec; 27(6):3536-7. PubMed ID: 8540089
[No Abstract] [Full Text] [Related]
13. Randomized double-blinded comparison of three intravenous immunoglobulin products in bone marrow transplantation.
Peltier MK; Filipovich AH; Bechtel M; Dirksen CL; Englund JA
Semin Hematol; 1992 Jul; 29(3 Suppl 2):112-5. PubMed ID: 1324529
[TBL] [Abstract][Full Text] [Related]
14. Prophylactic use of immunoglobulin in bone marrow transplantation.
Ho WG; Winston DJ; Champlin RE; Gale RP
Int J Cell Cloning; 1986; 4 Suppl 1():174-80. PubMed ID: 3018101
[No Abstract] [Full Text] [Related]
15. Intravenous immunoglobulin: use in pediatric bone marrow transplantation.
Casper JT; Sedmak G; Harris RE; Carrigan DR; Baxter-Lowe LA; Ash RC
Semin Hematol; 1992 Jul; 29(3 Suppl 2):100-5. PubMed ID: 1324528
[No Abstract] [Full Text] [Related]
16. Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation.
Sullivan KM; Kopecky KJ; Jocom J; Fisher L; Buckner CD; Meyers JD; Counts GW; Bowden RA; Peterson FB; Witherspoon RP
N Engl J Med; 1990 Sep; 323(11):705-12. PubMed ID: 2167452
[TBL] [Abstract][Full Text] [Related]
17. Complement and humoral immune parameters in bone marrow transplant recipients: effects of intravenous immunoglobulin administration.
Späth PJ; Baumgartner C; Gratwohl A; Doran JE; Elisa A; Bachmann P; Scherz R; Berger C; Morell A; Tichelli A
Transplant Proc; 1989 Feb; 21(1 Pt 3):3064-6. PubMed ID: 2495696
[No Abstract] [Full Text] [Related]
18. Donor leukocyte infusion for Japanese patients with relapsed leukemia after allogeneic bone marrow transplantation: lower incidence of acute graft-versus-host disease and improved outcome.
Shiobara S; Nakao S; Ueda M; Yamazaki H; Takahashi S; Asano S; Yabe H; Kato S; Imoto S; Maruta A; Yoshida T; Gondo H; Morishima Y; Kodera Y
Bone Marrow Transplant; 2000 Oct; 26(7):769-74. PubMed ID: 11042659
[TBL] [Abstract][Full Text] [Related]
19. Low incidence of acute graft versus host disease in Thai patients after allogeneic bone marrow transplantation.
Jootar S; Intragumtornchai T; Chuncharunee S; Seksan P; Hathirat P
Transplant Proc; 1994 Aug; 26(4):2354-6. PubMed ID: 8066773
[No Abstract] [Full Text] [Related]
20. The role of immunoglobulin in bone marrow transplantation.
Saral R
Transplant Proc; 1991 Aug; 23(4):2128-32. PubMed ID: 1871829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
